Skip to main content
Log in

Physical exercise as a modulator of the purinergic system in the control of sarcopenia in individuals with chronic kidney disease on hemodialysis

  • Review
  • Published:
Purinergic Signalling Aims and scope Submit manuscript

Abstract

The word sarcopenia derives from the Greek terms “sarx” for meat and “penia” for loss, thus being used to define reductions in muscle mass, muscle strength, and lower physical performance that compromise, mainly, the elderly population. Its high negative impact on patients’ quality of life encourages the production and publication of new studies that seek to find methods to prevent and reverse cases of loss of muscle mass and strength. Furthermore, the high prevalence of sarcopenia in patients with chronic kidney disease (CKD) is closely related to its pathophysiology, which consists of a state of increased protein catabolism and decreased muscle tissue synthesis. Also considering the inflammatory nature of CKD and sarcopenia, the purinergic system has been an important target of studies, which seek to relate it to the two previous conditions. This system achieves anti-inflammatory action by inhibiting, through adenosine, pro-inflammatory factors such as interleukin-12 (IL-12), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO), as well as by releasing anti-inflammatory substances such as interleukin-10 (IL-10). Simultaneously, the purinergic system presents pro-inflammatory activity, signaled by adenosine triphosphate (ATP), which occurs through the activation of T cells and the release of pro-inflammatory factors such as those mentioned above. Therefore, the ability of this system to act on inflammatory processes can promote positive and negative changes in the clinical aspect of patients with CKD and/or sarcopenia. Furthermore, it appears that there is a correlation between the practice of repeated physical exercise with the clinical improvement and in the quality of life of these patients, presenting a decrease in the levels of C-reactive protein (CRP), NTPDase, and the pro-inflammatory cytokine IL-6, such as increases in IL-10 resulting from modulation of the purinergic system. In this way, the present article seeks to evaluate the effect of physical exercise as a modulator of the purinergic system in the control of sarcopenia in patients with CKD on hemodialysis, in order to trace a relationship that can bring benefits both for biological markers and for quality of life of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

Not applicable.

Code availability

Not applicable.

References

  1. Moorthi RN, Avin KG (2017) Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens. https://doi.org/10.1097/mnh.0000000000000318

    Article  PubMed  PubMed Central  Google Scholar 

  2. Watanabe H, Enoki Y, Taruyama T (2019) Sarcopenia in chronic kidney disease: factors, mechanisms, and therapeutic interventions. Biol Pharm Bull. https://doi.org/10.1248/bpb.b19-00513

    Article  PubMed  Google Scholar 

  3. Yabuuchi J et al (2020) Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease. Sci Rep. https://doi.org/10.1038/s41598-020-74673-x

    Article  PubMed  PubMed Central  Google Scholar 

  4. Dwyer KM, Kishore BK, Robson SC (2020) Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nat Rev Nephrology. https://doi.org/10.1038/s41581-020-0304-7

    Article  PubMed  Google Scholar 

  5. Yang D, He Y, Muñoz-Planillo R, Liu Q, Núñez G (2015) Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 43(5):923–32. https://doi.org/10.1016/j.immuni.2015.10.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mathur N, Pedersen BK (2008) Exercise as a mean to control low-grade systemic inflammation. Mediat Inflamm. https://doi.org/10.1155/2008/109502

    Article  Google Scholar 

  7. Nunes RB, Alves JP, Kessler LP, Lago PD (2013) Aerobic exercise improves the inflammatory profile correlated with cardiac remodeling and function in chronic heart failure rats. Clinics. https://doi.org/10.6061/clinics/2013

    Article  PubMed  PubMed Central  Google Scholar 

  8. Greaney JL, Wenner MM, Farquhar WB (2015) Exaggerated increases in blood pressure during isometric muscle contraction in hypertension: role for purinergic receptors. Auton Neurosci. https://doi.org/10.1016/j.autneu.2014.12.003

    Article  PubMed  PubMed Central  Google Scholar 

  9. Miron V, Bottari N, Assmann C, Stefanello N, Costa P, Pelinson L, Reichert K, Silva A, Lopes T, Cruz I, Sévigny J, Morsch V, Schetinger M, Cardoso A (2019) Physical exercise prevents alterations in purinergic system and oxidative status in lipopolysaccharide-induced sepsis in rats. J Cell Biochem. https://doi.org/10.1002/jcb.27590

    Article  PubMed  Google Scholar 

  10. Sabatino A, Cuppari L, Stenvinke P, Lindholm B, Avesani CM (2021) Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 34:1347–1372. https://doi.org/10.1007/s40620-020-00840-y

    Article  PubMed  Google Scholar 

  11. Wang X, Mitch W (2014) Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol 10:504–516. https://doi.org/10.1038/nrneph.2014.112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kamijo Y, Kanda E, Ishibashi Y, Yoshida M (2017). Sarcopenia and frailty in PD: impact on mortality, malnutrition, and inflammation. Perit Dial Int: J Int Soc Perit Dial https://doi.org/10.3747/pdi.2017.00271

  13. Hirano T, Akira S, Taga T, Kishimoto T (1990) Biological and clinical aspects of interleukin 6. Immunol Today. https://doi.org/10.1016/0167-5699(90)90173-7

    Article  PubMed  Google Scholar 

  14. Tuttle C, Thang L, Maier A (2020) Markers of inflammation and their association with muscle strength and mass: a systematic review and meta-analysis. Ageing Res Rev. https://doi.org/10.1016/j.arr.2020.101185

    Article  PubMed  Google Scholar 

  15. Can B, Kara O, Kizilarslanoglu M, Arik G, Aycicek G, Sumer F, Civelek R, Demirtas UC, Ulger Z (2020) Serum markers of inflammation and oxidative stress in sarcopenia. Aging Clin Exp Res. https://doi.org/10.1007/s40520-016-0626-2

    Article  Google Scholar 

  16. Chu W (2012) Tumor necrosis factor. Cancer Lett. https://doi.org/10.1016/j.canlet.2012.10.014

    Article  PubMed  PubMed Central  Google Scholar 

  17. Malafrina V, Uriz-Otano F, Iniesta R, Gil-Guerrero L (2012) Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas 71(2):109–114. https://doi.org/10.1016/j.maturitas.2011.11.012

    Article  Google Scholar 

  18. Longo D Kasper D Harrison T (eds.) (2018). Harrison’s principles of internal medicine. New York, NY

  19. Derbré F, Gratas-delamarche A, Ratas-delamarche A, Gómez-Cabrera M, Mari C, Vinã J (2012) Inactivity-induced oxidative stress: a central role in age-related sarcopenia? Eur J Sport Sci. https://doi.org/10.1080/17461391.2011.654268

    Article  PubMed  Google Scholar 

  20. Haskó G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. https://doi.org/10.1038/nrd2638

    Article  PubMed  PubMed Central  Google Scholar 

  21. Zhou Y, Hellberg M, Hellmark T, Höglund P, Clyne N (2021) Muscle mass and plasma myostatin after exercise training: a substudy of renal exercise (RENEXC)—a randomized controlled trial. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfz210

    Article  PubMed  Google Scholar 

  22. Moon S, Kim T, Yoon S, Chung J, Hwang H (2015) Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the Korea National Health and Nutrition Examination Surveys. Plos One. https://doi.org/10.1371/journal.pone.0130740

    Article  PubMed  PubMed Central  Google Scholar 

  23. Avin K, Moorthi R (2015) Bone is not alone: the effects of skeletal muscle dysfunction in chronic kidney disease. Curr Osteoporos. https://doi.org/10.1007/s11914-015-0261-4

    Article  Google Scholar 

  24. Sawant A, Garland S, House A, Overend T (2011) Morphological, electrophysiological, and metabolic characteristics of skeletal muscle in people with end-stage renal disease: a critical review. Physiothe. https://doi.org/10.3138/ptc.2010-18

    Article  Google Scholar 

  25. Ziaaldini M, Marzetti E, Picca A, Murlasitis Z (2017) Biochemical pathways of sarcopenia and their modulation by physical exercise: a narrative review. Front Med (Lausanne) 4:167. https://doi.org/10.3389/fmed.2017.00167

    Article  PubMed  Google Scholar 

  26. Fahrner C, Hackney A (1998) Effects of endurance exercise on free testosterone concentration and the binding affinity of sex hormone binding globulin. Sports Med. https://doi.org/10.1055/s-2007.971872

    Article  Google Scholar 

  27. Kraemer W, Ratamess A (2005) Hormonal responses and adaptations to resistance exercise and training. Sports Med 35:339–361. https://doi.org/10.2165/00007256-200535040-00004

    Article  PubMed  Google Scholar 

  28. Virgilio F, Vuerich M (2015) Purinergic signaling in the immune system. Auton Neurosci. https://doi.org/10.1016/j.autneu.2015.04.011

    Article  PubMed  Google Scholar 

  29. Zyma M, Pawliczak R (2020) Characteristics and the role of purinergic receptors in pathophysiology with focus on immune response: purinergic receptors are widely expressed in immune cells and regulate high variety of their functions, taking part in pathogenesis of many diseases. Int Rev Immunol. https://doi.org/10.1080/088301.2020.1723582

    Article  PubMed  Google Scholar 

  30. Sharif K, Watad A, Bragazzi NL, Lichtbroun M, Amital H, Shoenfeld Y (2018) Physical activity and autoimmune diseases: get moving and manage the disease. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2017.11.010

    Article  PubMed  Google Scholar 

  31. Schmidt T, van Mackelenbergh M, Wesch D, Mundhenke C (2017) Physical activity influences the immune system of breast cancer patients. J Cancer Res Ther. https://doi.org/10.4103/0973-1482.150356

    Article  PubMed  Google Scholar 

  32. Da Silveira MP, da Silva Fagundes KK, Bizuti MR, Starck E, Rossi RC, de Resende e, Silva DT, (2021) Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature. Clin Exp Med 21:15–28. https://doi.org/10.1007/s10238-020-00650-3

    Article  CAS  PubMed  Google Scholar 

  33. Vianna HR, Soares CMBM, Tavares MS, Teixeira MM, Silva ACS (2011) Inflamação na doença renal crônica: papel de citocinas. J Bras Nefrol. https://doi.org/10.1590/s0101-28002011000300012

    Article  PubMed  Google Scholar 

  34. Da Luz Scheffer D, Latini A (2020) Exercise-induced immune system response: anti-inflammatory status on peripheral and central organs. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis https://doi.org/10.1016/j.bbadis.2020.165823.

  35. Svensson M, Lexell J, Deierborg T (2015) Effects of physical exercise on neuroinflammation, neuroplasticity, neurodegeneration, and behavior: what we can learn from animal models in clinical settings. Neurorehabil Neural Repair 29(6):577–589. https://doi.org/10.1177/1545968314562108

    Article  PubMed  Google Scholar 

  36. Acanfora D, Scicchitano P, Casucci G, Lanzillo B, Capuano N, Furgi G.Ciccone M M. (2016) Exercise training effects on elderly and middle-aged patients with chronic heart failure after acute decompensation: a randomized, controlled trial. Int J Cardiol https://doi.org/10.1016/j.ijcard.2016.10.026

  37. Cardoso AM, Silvério MNO, de Oliveira Maciel SFV (2021) Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review. Purinergic Signal 17(4):649–679. https://doi.org/10.1007/s11302-021-09816-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Cardoso A, Abdalla F, Bagatini M, Curry M, Zanini D, Roberta S, Augusto J, Rosa D, Morsch V, Chitolina M (2015) Swimming training prevents alterations in ecto-NTPDase and adenosine deaminase activities in lymphocytes from Nω-nitro-L-arginine methyl ester hydrochloride induced hypertension rats. J Hypertens 33(4):763–772. https://doi.org/10.1097/HJH.0000000000000468

    Article  CAS  PubMed  Google Scholar 

  39. Pedersen BK (2013) Muscle as a secretory organ. Compr Physiol 3. https://doi.org/10.1002/cphy.c120033

  40. Wackerhage H, Schoenfeld BJ, Hamilton DL, Lehti M, Hulmi JJ (2019) Stimuli and sensors that initiate skeletal muscle hypertrophy following resistance exercise. J Appl Physiol 126(1):30–43. https://doi.org/10.1152/japplphysiol.00685.2018

    Article  CAS  PubMed  Google Scholar 

  41. Lee JH, Jun HS (2019) (2019) Role of myokines in regulating skeletal muscle mass and function. Front Physiol 30:10. https://doi.org/10.3389/fphys.2019.00042

    Article  CAS  Google Scholar 

  42. Burnstock G (2018) The therapeutic potential of purinergic signalling. Biochem Pharmacol. https://doi.org/10.1016/j.bcp.2017.07.016

    Article  PubMed  Google Scholar 

  43. Domingos LB (2020) O envolvimento do sistema purinérgico na formação e extinção da memória aversiva condicionada em camundongos. Universidade de São Paulo, Dissertação

    Book  Google Scholar 

  44. Cardoso A, Bagatini M, Martins C, Martins C, Abdlla F, Zanini D, Gutierris R, Pimentel V, Thome G, Leal C, Vieira J, Stefanello N, Fiorin F, Baldissareli J, Royes L, Morsch V, Schetinger M (2012) Exercise training prevents ecto-nucleotidases alterations in platelets of hypertensive rats. Mol Cell Biochem. https://doi.org/10.1007/s11010-012-1431-7

    Article  PubMed  Google Scholar 

  45. Monaghan et al (2021) Biochem Pharmacol 187:114389. https://doi.org/10.1016/j.bcp.2020.114389

  46. Di Virgilio F, Sarti AC, Coutinho-Silva R (2020) Purinergic signaling, DAMPs, and inflammation. Am J Physiol Cell Physiol. https://doi.org/10.1152/ajpcell.00053.2020

    Article  PubMed  Google Scholar 

  47. Lammers MD, Anéli NM, de Oliveira GG, Maciel SFVO, Zanini D, Manica A, de Resende e Silva DT, Bagatini MD, Sévigny J, de Sá CA, Manfredi LH, Cardoso AM (2020) The anti-inflammatory effect of resistance training in hypertensive women: the role of purinergic signaling. J Hypertens 38(12):2490–2500. https://doi.org/10.1097/HJH.0000000000002578

    Article  CAS  PubMed  Google Scholar 

  48. Ferrari D, McNamee E, Idzko M, Gamabari R, Etlzschig (2016) Purinergic signaling during immune cell trafficking. Trends Immunol. https://doi.org/10.1016/j.it.2016.04.004

    Article  PubMed  Google Scholar 

  49. Menzies R, Unwin R, Bailey A (2014) Renal P2 receptors and hypertension. Acta Physiol 213:232–241. https://doi.org/10.1111/apha.12412

    Article  CAS  Google Scholar 

  50. Bailey M, Hilman K, Unwin R (2000) P2 receptors in the kidney. J Auton Nervous System 1–3:264–270. https://doi.org/10.1016/S0165-1838(00)00125-9

    Article  Google Scholar 

  51. Menzies R, Tam F, Unwin R, Bailey A (2016) Purinergic signalling in kidney disease. Kidney Int 91:2-315–323 https://doi.org/10.1016/j.kint.2016.08.029

  52. Wilkinson T, Shur N, Smith A (2016) Exercise as medicine in chronic kidney disease. Scandinavian J Med Sci Sports. https://doi.org/10.1111/sms.12714

    Article  Google Scholar 

Download references

Funding

FAPESC-Research Support Foundation of the State of Santa Catarina.

Author information

Authors and Affiliations

Authors

Contributions

G.V.S.S., M.R.B., and D.T.R.S. contributed to the conception, project administration, and supervision. N.R.O., L.Z.M.L., V.C.G.S.A., A.C.G.Z., C.Z., and J.G.P. contributed to the formal analysis, investigation, and methodology. D.T.R.S. supervised the methodology. G.V.S.S., M.R.B., and F.B.H. contributed to the writing and translation of the original draft. M.R.B. and D.T.R.S. revised the final work.

Corresponding author

Correspondence to Débora Tavares de Resende e Silva.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflicts of interest

The authors declare no competing interests.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Resende e Silva, D.T., Bizuti, M.R., de Oliveira, N.R. et al. Physical exercise as a modulator of the purinergic system in the control of sarcopenia in individuals with chronic kidney disease on hemodialysis. Purinergic Signalling (2023). https://doi.org/10.1007/s11302-023-09950-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11302-023-09950-1

Keywords

Navigation